HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Manns Selected Research

Viremia

6/2009The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Manns Research Topics

Disease

8Infections
10/2018 - 03/2000
3Hepatocellular Carcinoma (Hepatoma)
10/2018 - 03/2000
3Chronic Hepatitis C
10/2014 - 05/2000
3Acute Liver Failure (Fulminant Hepatic Failure)
07/2009 - 08/2000
2Liver Cirrhosis (Hepatic Cirrhosis)
10/2014 - 05/2001
2Chronic Hepatitis B
07/2011 - 09/2001
2Neoplasms (Cancer)
07/2009 - 05/2001
2Carcinoma (Carcinomatosis)
05/2001 - 04/2001
1Liver Diseases (Liver Disease)
10/2018
1Fibrosis (Cirrhosis)
10/2018
1Portal Hypertension
12/2015
1Disease Progression
10/2014
1Hepatitis E
07/2011
1Leukemia
07/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2009
1Massive Hepatic Necrosis
07/2009
1Hepatitis C
06/2009
1Viremia
06/2009
1Vascular Diseases (Vascular Disease)
03/2006
1Renal Insufficiency (Renal Failure)
03/2006
1Hypertension (High Blood Pressure)
03/2006
1Cholangiocarcinoma
05/2001
1Neoplasm Metastasis (Metastasis)
04/2001
1Peritoneal Neoplasms
04/2001
1Residual Neoplasm
04/2001
1Pancreatitis
08/2000
1Chronic Pancreatitis
08/2000
1Hereditary pancreatitis
08/2000
1Virus Diseases (Viral Diseases)
03/2000
1Hepatitis
03/2000

Drug/Important Bio-Agent (IBA)

4Antiviral Agents (Antivirals)IBA
10/2018 - 06/2009
3InterferonsIBA
10/2018 - 05/2000
2Interferon-alpha (Interferon Alfa)IBA
01/2012 - 06/2009
2Lamivudine (Epivir)FDA Link
07/2009 - 09/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2000 - 03/2000
14-(3-chlorophenylsulfanyl)piperidineIBA
12/2015
1Ribavirin (Virazole)FDA LinkGeneric
01/2012
1telaprevirIBA
01/2012
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2012
1Protease Inhibitors (Protease Inhibitor)IBA
01/2012
1AntigensIBA
07/2011
1Hepatitis B e AntigensIBA
07/2011
1Proteins (Proteins, Gene)FDA Link
07/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2009
1EnzymesIBA
06/2009
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2006
1Famciclovir (Famvir)FDA LinkGeneric
09/2001
1GemcitabineFDA Link
05/2001
1Antineoplastic Agents (Antineoplastics)IBA
05/2001
1TrypsinogenIBA
08/2000
1TrypsinIBA
08/2000
1Peptides (Polypeptides)IBA
08/2000
1Enzyme Precursors (Zymogens)IBA
08/2000
1Codon (Codons)IBA
08/2000
1Caspase 3 (Caspase-3)IBA
03/2000
1DNA (Deoxyribonucleic Acid)IBA
03/2000
1Messenger RNA (mRNA)IBA
03/2000
1NF-KappaB Inhibitor alphaIBA
03/2000
1LuciferasesIBA
03/2000
1Fas Ligand Protein (Fas Ligand)IBA
03/2000

Therapy/Procedure

6Therapeutics
10/2018 - 05/2000
2Liver Transplantation
10/2018 - 07/2009
2Drug Therapy (Chemotherapy)
07/2009 - 05/2001
1Hyperthermic Intraperitoneal Chemotherapy
04/2001